학술논문
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial
Document Type
Article
Author
Source
In: The Lancet Neurology . (The Lancet Neurology, June 2022, 21(6):511-519)
Subject
Language
English
ISSN
14744465
14744422
14744422